Navigation Links
GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
Date:2/14/2008

iety of innovative variations on existing protein drugs including cytokines, growth factors, coagulation factors, hormones and their receptors.

GenOdyssee's lead IFN alpha products are natural human proteins variants generated by natural evolution. They are therefore already proven to be functional and tolerated in man, echoing that of the marketed interferon-alpha 2a and 2b drugs from Roche and Schering-Plough that define the current standard of care.

GenOdyssee's IP portfolio is constituted of fifty-two patents and patent applications that cover both its innovative technology and therapeutic products, representing seven different patent families among which twenty patents are already granted in numerous countries worldwide including the EU and the US.

For more information about the company, please visit the company's website at http://www.genodyssee.com


'/>"/>
SOURCE GenOdyssee SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Quintiles Central Laboratory in India Receives CAP Certification
2. Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
3. Photo: Animal Rescue League of Boston Receives $3 Million Grant to Establish a Center for Shelter Dogs
4. Stereotaxis Receives $20 Million in Additional Loan Commitments
5. MedApps Receives Prestigious Frost & Sullivan Award
6. IDM Pharma Receives Notification from NASDAQ Relating to Minimum Bid Price
7. Ludwig Institute for Cancer Research receives NHMRCs largest 2009 grant
8. Jacobs Receives Contract from Catholic Healthcare West to Assist Sequoia Hospital Expansion Program
9. Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R)
10. Regions Hospital Receives National Quality Awards
11. Laser Energetics Receives a $550,000 Order for a Dental Laser System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... India Network visitor health insurance announced ... visitors who purchase the plan before arrival in the ... purchase the insurance program as soon as travel plans ... pre-existing medical conditions. Parents and grandparents traveling from India ... serious consequences to their health. Many visitors may not ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... injuries is a growing field in orthopaedic medicine. While ... labral tear to confirm the pain etiology, research presented ... ( AOSSM ) Specialty Day suggests that pain relief ... following arthroscopic hip surgery. , “Our study looked ...
(Date:3/28/2015)... March 28, 2015 Lately the ... regarding recent changes and proposals around the NCAA. In ... and former collegiate student-athletes across a spectrum of universities ... on common challenges. The special panel consists of athletes ... sports ranging from football, track and field, baseball, and ...
(Date:3/28/2015)... March 28, 2015 ARDX will sponsor the ... 12pm -3pm at the Chesapeake Conference Center in Chesapeake, Virginia. ... an empowering event for women in the Hampton Roads region. ... Stories of Women’s Lives. Women grow stronger through sharing ... other. This year the WWC™ theme is T-talk where ...
(Date:3/27/2015)... Wellness for Cancer–the first organization to ... the spa and wellness industry–has certified Hands On to ... or are living with cancer. Hands On , ... will be identified with a special Wellness for Cancer ... safe, therapeutic services for cancer patients. , Wellness for ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Pain Injections for Hip Arthroscopy Patients May Not Predict Surgical Outcomes 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 3Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Certified as “Cancer Aware” by Wellness for Cancer and Recognized on Spafinder.com 4
... Its Educational and Entertaining MusicMINNETONKA, Minn., May 6 ... activities for young children, today announced that its founder, ... The National Parenting Center for her new CD, "Dance ... "really impressed ... with its ability to entertain and ...
... SOUTH SAN FRANCISCO, Calif., May 6 Sunesis Pharmaceuticals, ... results for the first quarter ended March 31, 2009.Total ... million, with a net loss of $8.4 million, including ... 2009, cash, cash equivalents and marketable securities totaled $4.3 ...
... China, May 6 /PRNewswire-Asia/ -- China Medicine ... "the Company"), a developer,and a leading distributor ... Chinese medicines (TCM), nutritional and dietary supplements, ... that it will conduct,a conference call at ...
... NeoStem, Inc. (NYSE Amex: NBS ), ... storage of adult stem cells for future medical need, ... cell technology of Vincent C. Giampapa, M.D., F.A.C.S. ... in February 2009.The newest adult stem cell collection center ...
... ENMD ), a clinical-stage pharmaceutical company developing ... today reported financial results for the three months ended ... ) , The Company reported a net loss ... ($0.04) per share, compared with a net loss of ...
... Md., May 6 Micromet, Inc. (Nasdaq: ... for the treatment of cancer, inflammation and autoimmune diseases, ... ended March 31, 2009.In the first quarter of 2009, ... continued progress in the clinic and in corporate development. ...
Cached Medicine News:Health News:Tessa, of Dancercise Kids, Wins the National Parenting Center's Seal of Approval for New Children's Music CD 2Health News:Sunesis Reports Financial Results for the First Quarter 2009 2Health News:Sunesis Reports Financial Results for the First Quarter 2009 3Health News:Sunesis Reports Financial Results for the First Quarter 2009 4Health News:Sunesis Reports Financial Results for the First Quarter 2009 5Health News:Sunesis Reports Financial Results for the First Quarter 2009 6Health News:Sunesis Reports Financial Results for the First Quarter 2009 7Health News:Sunesis Reports Financial Results for the First Quarter 2009 8Health News:Sunesis Reports Financial Results for the First Quarter 2009 9Health News:China Medicine Announces Conference Call to Discuss First Quarter 2009 Results 2Health News:NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey 2Health News:NeoStem Files Patent Application for Cosmetic Stem Cell Face Lift Technology and Expands Stem Cell Collection Network into New Jersey 3Health News:EntreMed Reports First Quarter 2009 Financial Results 2Health News:EntreMed Reports First Quarter 2009 Financial Results 3Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 2Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 3Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 4Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 5Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 6Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 7Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 8Health News:Micromet, Inc. Reports First Quarter 2009 Financial Results 9
(Date:3/27/2015)... , March 27, 2015 XRpro ... for drug discovery and development services which features ... the pharmaceutical industry, announced financial results for the ... Timothy C.  Tyson, Chairman of XRpro Sciences commented, ... successfully transition from development stage to commercial stage ...
(Date:3/27/2015)... March 27, 2015 According to ... (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, ... Indication (AF, VT, WPW) - Global Forecasts to 2019 ", ... to reach around ~$4.73 Billion by 2019 with a ... to 2019. Browse   90   ...
(Date:3/27/2015)... , March 27, 2015  RXi Pharmaceuticals ... MirImmune LLC, today announced that they have ... RXi,s novel and proprietary sd-rxRNA® technology for ... The collaboration has the potential to result ... cancer treatments that could be a significant ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... Inc. (NASDAQ: STXS ) today announced that ... to be held on December 13-14, 2011 in New ... Stereotaxis, is scheduled to present an overview of the ... ET.  A live webcast and subsequent ...
... YORK, Dec. 2, 2011 Levi & Korsinsky is ... Abbott Laboratories, Inc. ("Abbott" or the "Company") (NYSE: ... regarding the marketing and sale of the anti-seizure medication ... http://zlk.9nl.com/abbott-laboratories-abt . From as early as 1998, ...
Cached Medicine Technology:Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011 2Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011 3The Law Firm of Levi & Korsinsky Launches an Investigation Into Possible Breaches of Fiduciary Duties and Unjust Enrichment by the Board of Directors of Abbott Laboratories, Inc. 2
For the quantitative determination of calcium in serum. Endpoint Reaction Product measured at 570 nm Linearity: 20 mg/dl...
Alanine Aminotransferase (ALT) reagent is used for the quantitative determination of alanine aminotransferase (Glutamate pyruvate transaminase, SGPT) in human serum....
... Intended for the quantitative determination ... serum or plasma. Two vials, ... tablets must be purchased separately ... Kinetic reaction. Wavelength: 340 nm. ...
... quantitative determination of alanine aminotransferase ... Single vial, dry powder reagent. ... purchased separately for conformity to ... 340 nm. Linearity: 440 U/L ...
Medicine Products: